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Sonic&d albumin has been used clinically lo improve 
eodoeardiat border resolution during exercise stress echo- 
cardiography (l,Z). The improved eadcxxrdial rcsolutioa 
assists in identifyioa wall motion abnormalities that may 
have gone undetected without this ul~rasoond coatrrst 
agent. When albumin is sonicated with dextrose. the result- 
ing ultrasound contrast agent improves IeR veatricoler cw- 
ity uptake (3,4). Therefore, we hypothesized that this agent 
could be used successfully during dobutaminc stress echo- 
cardiography IO improve endowdial border detection and to 
assist in making the clinical diagnosis of stress-induced 
ischemia in humans. 
Methods 
Fiiy patients (29 men, 21 women, mean [?SD] age 64 + 
13 years) undergoing dobatamine stress echocardiography to 
detect the presence or absence of significant coronary artery 
disease underwent contrast agent studies. The study was 
approved by the University of Nebraska institutional Re- 
view Board for the Protection of Hamaa Research Subjects. 
After basclim i-s were obtaiocd from the pamsternal 
loo@ sod shot&&s aod apu foar-. two.. sod lhree- 
chamber views, incremental dobutamine infusion at 5, IO, 
20. 30.40 and 54 & bdy weight per min occorred at 
J&I intervals. Wail motion sod thickeoioa were aoalvzed 
using the l6wgment model of Sawada et>. (5). At Ah 
stage. oltrasooad imsges from all views. LI well as blood 
pressure aod ekctnxardii (EC@ ttac.$Ss, were 
repeated. A positive dobutamiae stress echow&mo~ 
dellaed as a MW or worsenhtg wall owtioa aboom&? 
any stage dating the itiusioo. 
Prew&itd&msewlcmtraiuab. Thcultmsoaod 
contra& gent osed for assessing I& veolricular border 
to wvenfold) of albumin with 50% dextrose. Admiaistmtion 
of this agent results in more consistent left ventt&lar 
chamber opacitkatioa aRer intmvaaoos iajection itt humans 
than sonicated albatnin (6). The sonicatioo technique was 
similar to that descrii by Kdkr et al. (7). In each case 
-16 trd of the threefold to sevenfold dilution was placed in a 
35.ml syringe. A commercially available sooicator (Heal 
Systems Ultrasonics, model XL202o) equipped with a sterile 
0.5.in. (I .27 rm) horn was then used lo create the micmbub- 
bles. The 0.5-i& horn was placed at the solution surface 
while contiooous soaication proceeded at a frequency of 
20 kHz and a pwer setting of -30% maximal output for SO 
to 100 6. The solution was then kept io a sterde syringe until 
intravenous injection. Microbubble concentration of these 
samples determined by Coullcr counter ranged from 
3.9 x Id to 4.6 x 108 microbubblesiml. Mean microbubble 
size determined 5y hemocytomelry was S.5 % 3.0 mum. 
The stability of these samples was determined by mea- 
suring the microbubble concentration of three different sam- 
pies 4 months after production. Mean microbubble concen- 
&ion of these samples was 4.3 x 10’ microbobbleslml 
(i-awe 3.4 lo 4.1 x 108 microbubbleslml). Therefore. there 
&as-minimal change in the microbubble concentration of 
wnicated dextrose albumin over this time period 
Stady pmtoml. After obtaining baseline ultrasound im- 
ages, the apical four-chamber view was imaged again and 
used for comparison of ultrasound contrast agent uptake 
tpe& video intensity) with border resolution at baseline, 
10 &kg pr min and peak dobutamine infusions. At these 
three stages. en 8.1%ml injection of the ronicatcd dextross- 
albumin was given for 3 to 5 s and immediately followed bv 
a IO.C-ml s&ae solution Rush. In S of the SO p&t&. 
ultrasound contrast was given only during baseline and peak 
dobutamine infusions. 
Images were digitized using the digital storage and re- 
trieval system on the Hewlett-Packard Sonos IS00 Phased 
Array system. End-diastolic images were digitized after 
initial appearame of contrast agent in the right ventricle. The 
digitized video images were obtained at every R wave on the 
ECG until either complete disappexencc of contrast from 
the lefi venlricle or the maximal number of stored frames 
was reached (60 frames). These images were then stored on 
lhe optical disk and rclrieved later for analysis. The analysis 
was parformed using Acoustic Densitometry software 
(Hewlett-Packard). A 31 X 3 I-pixel circular cross hair was 
placed in the mid-left ventricular cnvity. Video intensity 
withio the cross hair was then quanlifled at enddiastolc. 
Video intensity versus time curves were generated thnt 
derived peek video intensity in the re8ion of interest. Peak 
video intensity was measured at baseline. IO-&k8 per min 
aad peak dobutamine infusions. 
ReaLlime images were stored on 0.5.in. videotape for 
anslysis of conttast agent persistence. This was defined as 
the number of seconds the: there was suiTtcien1 contrast 
agent in the IeR ventricle lo improve endocardial border 
resolution in at leas1 one ijmsni. In addition, the number of 
cardiac cycles with adequate contrast agent (lo determine 
endocwdial borders) present in the left ventricular cavity 
was also counted at each stape. 
Aa+& of impmwd cndaeudiel border resolution. Two 
experienced cardiologists who had no knowledge of the 
patients’ clinical results reviewed the real-time or digitized 
apical fmwhamber images after ultrasound contrast agent 
injections. These images were divided into basal. mid and 
apical septal and lateral segments, and endocardial border 
resolution after contrast agent injections was graded in each 
se8meot es follows: 1 = no improvement in border resolu- 
tion; 2 = improved border detection; and 3 = marked improve- 
ment io border resolution. Improved endocardial border 
Table 1. Baseline Hemodynzmic and Let? Ventricular Ultrasound 
Contnsr Variables at Baseline md During Dobutamine lrti~sios in 
50 Swdy Patients 
resolution MS defined according to previous criteria as an 
improvement (a grade of 2 or 3) in resolution in at least one 
of the six sc8ments (I). 
Slnt~stic~ muIysis. Peak left ventricular video intensity 
and contrast agent persistence were compared between the 
three dobutamine infusions using Kruskal-Wallis one-way 
analysis of variance on ranks. This nonparanxtric test was 
performed because the data were not distributed normally. 
Comparisons between heart rate and systolic blood pressure 
between the three dobutnmine stages n’ere made using a 
Student-Newman-Keuls multiple comparison procedure, 
and p < 0.05 was considered significant. 
Results 
Of the 50 patients studied, 20 had Positive results for 
ischemia. and 30 had negative results. In two patients, no 
contrast agent injections were given at peak dobutamine 
infusion because the contrast agent during the low dose 
dabutamine infusion caused a burning pain at the intrave- 
nous site. There were no instances of phlebitis and no other 
complications associated with the contrast agent injections. 
Baseline mean heart rate was 67 ? I3 beatslmin and in- 
creased to 76 f IS beats/min during the lO~&ka per min 
infuusioo. Al the ppak infusion injection. mean heart rate 
increased to I26 * IS beatslmln (P < 0.005). Despite wide 
variation in systolic bled p&we responses & dobat- 
amine, there were no significant mean changes in systolic 
blood pressure at any of the three injections. 
The results of peak video intensity and contrast agent 
persistence (in seconds and cardiac cycles) for contrast 
agent injections at the three stages are displayed in Table 1. 
Left ventricular contrast agent opacification after inlrave- 
nous iniection occurred in 67% of all cases at baseline and 
92% of*all cases at peak dobutamine infusion. Although left 
ventricular video intensity improved after cmmxt agent 
injections during the low dose dohutamine infusion, peak 
video intensity in the mid-left ventricular cavity increased 
significantly only at peak dobutamine infusion (p = 0.002). 
F&e 1. Improved endowdial border resolution during low dose 
(10 pm&g per minj infusion of dobutamino. At end.dhtdc (A nnd 
B), Ik ronieatcd dextrose albumin improved lateral border reaolu- 
lion (urmvs). At end.systole (C and D). there is impwed en&car- 
dial border resolution along both septal and lateral borders (rmn). 
Contrast agent persistence in the left ventricular cavity (in 
seconds) was not significantly different at the three differenl 
dobutamine slages. However, the number of cardiac cycles 
in which there was left ventricular opaciticalion was signif- 
icantly greater at peak dobutamine infusion (p c 0.005) 
(Table I). 
FJtdwwdiaI border res4hltkm wttb soakated dextrose at. 
bumln. All studies evaluating the efficacy of inlravenous 
sonicated dextrose albumin to improve endocsrdial border 
resolution were from the six segments in the apical foor- 
chamber view. Without contrast agent, there was inadequate 
border resolution in at least one segment of this view in 37 of 
the SO patients. In >90% of these 37 patients, the majority of 
segments that were inadequately visualized were the basal. 
mid or aoical lateral wall. intravenous sonicated dextrose 
albumin &wwed border resolution in at least we inadc- 
quately visualized segment in 25 (68%) ofthcse 37 patients at 
baseline. At the IO&kg per min infusion. 93% of the 
patients with at least one poorly visualized segment had 
improvement in endocardial border resolution of these seg- 
ments after intravenous contrast agent administration. At 
peak dobutamine infusion, 35 (95%) of the 37 patients had 
improvement of border resolution of a previously insde- 
quately visualized segment after administration of sonicated 
dextrose albumin. Figure I demonstrates the improved end- 
diastolic and end-systolic border resoludon with ultrasound 
contrast agent during a low dose dab&mine infusion. 
To test interobserver agreement on whether there was 
improvement in endocardiai border resoiution, both ohsew 
ers analyzed the same case in 22 patients in a blinded 
manner. At baseline, there was agreement hat resolution of 
at least one segment was improved with contrast agent in 
77% of injections. This agreement behveen observers in- 
creased to UN% at the contrast agent injections performed at 
low dose (IO &kg per min) and peak dobutamine infusion. 
Di.wussion 
This study demonstrates that intravenous sonic&d dex- 
trose albumin can be utilized to improve endowdial border 
resolution during dobwamine stress e&cardiography. Left 
ventricular chamber contrast was improved the best at peak 
dobutaodm infusion, hot endowdial border resolution was 
improved in SQ% of patients with previously inadequate 
resolution at both the low dose and peak infusions. Atthoogh 
this stady evaluated how ultrasound contrast agent adrain- 
istration improved border resoMion only from the apical 
fowchamber view, we fowl the improved resoIution to be 
especially belpfal in deliwaring lateral wall endocardial 
motion. We used a modification of sonicated aNnonia (soo- 
icated dextrose alboodn) becaose we fooad that it sianifi- 
cantly improves transpolmooary passage of albumin n&ro- 
bubbles compared with sookated albumin alom io honuos 
16). Mean microbobble diameter of this aaenl (5.5 urn) is 
;l&tly larger than the 4 to S-pm diier r&u&d .for 
sonicaced albumin (Alboaex). This small increase in mi- 
crobabbk diameter will sot atTect the transpolmoaary pas- 
sage bat will exponentially increase oltrawmd rafkctaoce 
sod thus may accooot for its improved kft ventricular video 
intensity. 
wmvadkELv--4ww@f=daw 
dobrlriM i#aska. We observed signhYcaa1 increases in 
kn ventrkolar cootrast video intensity and number of coo- 
trast agent-enhanced cardiac cvcles at pd: infusion com- 
pared with the same injrction given at baselim. The most 
likely explanation for this is the deereased rmnspolmooary 
transit time from increased cardiac output. Iajeetions of 
contrast agent during the low dose (IO @kg per min) 
dobutamiae infusion alw improved kR ventrudar o&ii- 
cation and border resolution bccausc of increased cardiac 
outpul d&pile only mioorchanges in heart rate. Because the 
same dose of wntrast agent at peak dobutamine infusion 
further improved let? ventricular video intensity compared 
with the 1i.v dose infusion, we assume that the chrooot&pic 
effect of dobutamiae also played a role in improving 
transpolmonary passage. 
Improved endoeavdht bet& resalutka wtth attraxwad 
eu~tmxt a&ant. lmpmvfd endocardial border resolution was 
seen in 93% of our wtients with inadequate resolution at 
baseline during the low dose infusion &d in 9S% at peak 
infusion. There are advantages to using intravenws ultra- 
sound contrast agent at low aad peak infusions of dobut- 
amine. 
I) Dobutamine stress echocardiography at low doses 
appears to identify viable, stunned or hibernating myocar- 
dium (8-10). Therefore, the improved endocardial border 
resolution with intravenous ullrasound contrast agent at this 
infusion level could improve the sensitwity of this test in 
identifying these conditions. 
2) The sensitivitv of dobutamine stress for identifvinz a 
new or worseoing~wall motion abnormality (iuhemial ar 
peak infusion varies from 75% to 99% (5. I I .12). Because the 
lateral wall segments are often poorly visualized during 
echocardiogmphy because of dropout. it is possible that 
ultrasound contrast agent could further improve the sensi- 
tivity of dobtttamine in detecting ischemia because of im- 
proved resolution in these segmeits (Fig. I). 
Study IimMions. This studv is limited in its abilitv to 
define f;ow often an improved eidocardial border resol&on 
with ultrasound contrast agent improved clinical decision 
making. Because we retrospa iively asked our reviewers to 
make decisions on endowdial border resolution in a blinded 
manner. this study cannot answer this question accunteiy. 
Funhertnore, we only imaged the apical four-chamber view 
in most of the patients during this study. nnd often the new 
or worsening wall motion abnonality would have been seen 
only in other views. Howcvcr. the increased numter ot’ 
contrast agent-enhanced cardiac cycles we obsewed at peak 
dobutamine infusion suggests that this ultrasound contrast 
agent could be utiliied to image multiple views with one 
injection. A prospective evaluation of the ability of this 
ultrasound contrast agent in improving the sensitivity and 
specificity of dobutamine stress echocardiography. there- 
fore, could be performed with B minimal number of inja 
tions. 
Coaclurdw. lnttwettous sonicatcd dextrose albumin 
si!gniticimtly improves endoardial border resolution during 
dobutamine stress echocardiography. This improvement 
was most helpful in identifying tatenl well endocardial 
motion. Tke resolution is improved best a’ low dose and 
peak infusions of dobutamine and thus may be clinically 
ttscful in improving the sensitivity and specificity of dobul- 
amine stress echocardiogmphy. 
